| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/11/2006 | US7074392 for high penetration into fingernails and toenails; contains humectant for trapping water and liquid nail lacquer containing film forming agent |
| 07/11/2006 | CA2395114C 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 07/11/2006 | CA2364824C Anti-bacterial composition to be diffused to fight bacteria contained in the air and the process for diffusing such a composition |
| 07/11/2006 | CA2319201C Celecoxib compositions |
| 07/11/2006 | CA2298704C Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
| 07/11/2006 | CA2293793C Rapamycin formulations for oral administration |
| 07/11/2006 | CA2285548C Nicotinamide derivatives |
| 07/11/2006 | CA2212552C Hepatitis b vaccine |
| 07/11/2006 | CA2182273C L-nucleosides for the treatment of hepatitis b-virus and epstein-bar virus |
| 07/11/2006 | CA2168447C Compounds and methods for inhibition of hiv and related viruses |
| 07/06/2006 | WO2006071564A2 Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents |
| 07/06/2006 | WO2006070943A1 Condensed imidazole compound and use thereof |
| 07/06/2006 | WO2006070927A1 Pyrimidinylisoxazol derivative |
| 07/06/2006 | WO2006070891A1 Novel strain conferring anti-disease properties to host and bacterial cell composition |
| 07/06/2006 | WO2006070874A1 Hypoxic response promoter |
| 07/06/2006 | WO2006070705A1 Intraoral disintegration type solid preparation containing povidone iodine |
| 07/06/2006 | WO2006070671A1 12-position substituted mutilin derivative |
| 07/06/2006 | WO2006070275A1 Process for obtaining levofloxacin free from salts |
| 07/06/2006 | WO2006070028A1 Pathogenic infection detection compositions and methods |
| 07/06/2006 | WO2006070004A1 Compounds useful in the treatment of hiv |
| 07/06/2006 | WO2006069533A1 Desmosdumotins, their manufactures and use as antitumor and anti-aids agent |
| 07/06/2006 | WO2006069512A1 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal composition containing them |
| 07/06/2006 | WO2006069449A1 Chemokine receptor-independent immunomodulatory and anti-proliferative activity |
| 07/06/2006 | WO2006069441A1 Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases |
| 07/06/2006 | WO2006046039A3 Tetracyclic indole derivatives as antiviral agents |
| 07/06/2006 | WO2006046030A3 Tetracyclic indole derivatives as antiviral agents |
| 07/06/2006 | WO2006044410A3 A32 monoclonal antibody fusion proteins for use as hiv inhibitors and vaccines |
| 07/06/2006 | WO2006040643A3 Polymorphic forms of efavirenz and processes for their preparation |
| 07/06/2006 | WO2006018682A3 Oxazolidinone derivatives as antimicrobials |
| 07/06/2006 | WO2005116002A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/06/2006 | US20060149041 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 07/06/2006 | US20060149039 Pseudo-native chemical ligation |
| 07/06/2006 | US20060148857 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 07/06/2006 | US20060148849 Quinoline derivatives, process of synthesis and medicaments containing these derivatives |
| 07/06/2006 | US20060148824 Administering compounds such as 6-Chloro-N-[(1R)-1-phenylethyl]pyrazin-2-amine for inhibiting a protein kinase |
| 07/06/2006 | US20060148788 Pyrrolobenzodiazepines |
| 07/06/2006 | US20060148765 7-Substituted fused ring tetracycline compounds |
| 07/06/2006 | US20060148751 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 07/06/2006 | US20060148726 Pharmaceutical compositions comprising flavonoids and menthol |
| 07/06/2006 | US20060148709 Neuroprotective properties of GDF-15, a novel member of the TGF-Beta superfamily |
| 07/06/2006 | US20060148087 Development of a preventive vaccine for filovirus infection in primates |
| 07/06/2006 | US20060147989 administering to mammals mixtures of plant extracts from ginger, green tea, turmeric, horseradish and carriers |
| 07/06/2006 | US20060147548 Therapeutic delivery of carbon monoxide |
| 07/06/2006 | US20060147544 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations |
| 07/06/2006 | US20060147496 Diagnosis of irritable bowel disorders; fibromyalgia; chronic fatique syndrome; antidepressants; tinnitus; autism; autoimmune disease; Crohn's disease; quantitative analysis of serotonine, bile acid in sample |
| 07/06/2006 | US20060147475 Ringworm vaccine |
| 07/06/2006 | US20060147474 Detection of antibodies against chamydia trachomatis PGP3 antigen in patient sera by enzyme-linked immunoassay |
| 07/06/2006 | US20060147468 Inactivated influenza virus vaccine for nasal or oral application |
| 07/06/2006 | US20060147466 Mucosal combination vaccines for bacterial meningitis |
| 07/06/2006 | US20060147464 immunogens; immunololgy; for production of vaccines; able to induce antiserum having neutralizing antibody; neutralization assay; Mareks Disease virus, infectious bronchitis virus, Newcastle disease virus, egg drop syndrome virus, turkey rhinotracheitis virus, or reovirus |
| 07/06/2006 | US20060147462 For diagnostic, prophylactic and therapeutic uses, vaccines against bacterial infections |
| 07/06/2006 | US20060147461 Use of ClyA hemolysin for excretion of proteins |
| 07/06/2006 | US20060147454 Human serine protease and serpin polypeptides |
| 07/06/2006 | US20060147434 Different dendritic cell subsets |
| 07/06/2006 | US20060146644 System for producing micro-cluster liquids |
| 07/06/2006 | DE102004063132A1 Use of bupropion having tumor necrosis factor inhibitory activity for the preparation of a medicament for the treatment of hepatitis C |
| 07/06/2006 | DE102004061746A1 Alkinyl-substituierte Thiophene Alkynyl-substituted thiophenes |
| 07/06/2006 | CA2594325A1 Condensed imidazole compound and use thereof |
| 07/06/2006 | CA2594229A1 2',3'-dideoxy-3'-c-hyroxymethylcytidine and prodrugs thereof for the treatment of drug escape mutant hiv |
| 07/06/2006 | CA2592141A1 Virus preparations and methods |
| 07/06/2006 | CA2592122A1 Oral care composition containing extract of unoxidized camellia |
| 07/06/2006 | CA2591912A1 Pyrimidinylisoxazole derivatives |
| 07/06/2006 | CA2591898A1 Mutilin-derivative substituted at position 12 |
| 07/05/2006 | EP1676856A1 Peptide originating in hepatitis c virus |
| 07/05/2006 | EP1676848A1 Polymorphous forms of rifaximin as antibiotics |
| 07/05/2006 | EP1676847A1 Polymorphous forms of rifaximin as antibiotics |
| 07/05/2006 | EP1676582A1 Anti-coronavirus agent |
| 07/05/2006 | EP1676575A2 Mucin production inhibitor |
| 07/05/2006 | EP1676551A2 Treatment of hepatitis C using hyperthermia |
| 07/05/2006 | EP1675942A2 Immunogenic composition and method of developing a vaccine based on cyclophilin a binding site |
| 07/05/2006 | EP1675873A1 Correlation between the fucose content / galactose content ratio of anti-rhesus-d and anti-hla-dr antibodies and the adcc activity |
| 07/05/2006 | EP1675854A1 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 07/05/2006 | EP1675853A1 Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors |
| 07/05/2006 | EP1675852A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 07/05/2006 | EP1675616A2 Novel igg3 antibodies for stimulating phagocytosis |
| 07/05/2006 | EP1675612A2 Immunogenic composition and method of developing a vaccine based on factor h binding sites |
| 07/05/2006 | EP1675605A1 Pharmaceutical composition which can be used, for example, as an antiviral or antibacterial agent and to stimulate immune defences |
| 07/05/2006 | EP1675547A2 Glucocerebroside treatment of disease |
| 07/05/2006 | EP1675459A1 Use of boranocarbonates for the therapeutic delivery of carbon monoxide |
| 07/05/2006 | EP1467744A4 Aqueous compositions containing metronidazole |
| 07/05/2006 | EP1418881A4 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 07/05/2006 | EP1401440A4 Methods of use of fluoroquinolone compounds against bacteria |
| 07/05/2006 | EP1390049B1 Compositions for treating animal diseases and syndromes comprising transfer factor |
| 07/05/2006 | EP1385844B1 Oxazolidinones containing a sulfonimid group as antibiotics |
| 07/05/2006 | EP1377575B1 Antiviral pyrazolopyridine compounds |
| 07/05/2006 | EP1368040B1 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases |
| 07/05/2006 | EP1283714B1 Use of lactobacillus casei in immunostimulatory compositions |
| 07/05/2006 | EP1274853B1 Materials and methods relating to immune responses to fusion proteins |
| 07/05/2006 | EP1235900B1 Microparticle-based transfection and activation of dendritic cells |
| 07/05/2006 | EP1225894B1 Fab i inhibitors |
| 07/05/2006 | EP1214344B1 Dipeptidyl peptidases |
| 07/05/2006 | EP1196559B1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 07/05/2006 | EP1183026B1 Improved pharmaceutical formulations comprising ritonavir |
| 07/05/2006 | EP1139755B9 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 07/05/2006 | EP0721506B1 Bacterial exported proteins and acellular vaccines based thereon |
| 07/05/2006 | CN1798834A Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclon |
| 07/05/2006 | CN1798764A Peptide inhibitors of toxins derived from ll-37 |
| 07/05/2006 | CN1798740A Nitrogen-containing heteroaryl derivatives |
| 07/05/2006 | CN1798728A Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 07/05/2006 | CN1798572A Interferon beta in severe acute respiratory syndrome (SARS) |